Mobile

Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine...

Update Il y a 4 ans
Reference: EUCTR2004-005205-30

Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine in patients with metastatic breast cancer previously treated with anthracyclines

Woman Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate simultaneously the response rate of the combination of oral vinorelbine with capecitabine, a sequential regimen of oral vinorelbine and capecitabine, and the combination of docetaxel and capecitabine for first line treatment of patients with metastatic breast cancer, after prior anthracycline containing (neo)- adjuvant regimen

Inclusion criteria

  • Patients with metastatic breast cancer previously treated with anthracyclines

Links